Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
52.94
-0.01 (-0.02%)
Apr 28, 2026, 4:00 PM EDT - Market closed

Terns Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2018
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2018
Net Income
-96.21-88.85-90.21-60.35-50.16
Upgrade
Depreciation & Amortization
0.50.90.881.030.51
Upgrade
Loss (Gain) From Sale of Investments
-0.06-2.09-5.210.080.88
Upgrade
Stock-Based Compensation
13.415.6325.5410.778.15
Upgrade
Other Operating Activities
0.510.020.140.390.22
Upgrade
Change in Accounts Payable
-0.51-0.371.15-0.721.73
Upgrade
Change in Other Net Operating Assets
0.194.750.33-0.32-3.15
Upgrade
Operating Cash Flow
-82.18-70.02-67.39-49.11-41.83
Upgrade
Capital Expenditures
--0.04-0.05-0.28-0.34
Upgrade
Investment in Securities
-298.04-12.37-37.94-22-119.36
Upgrade
Investing Cash Flow
-298.04-12.41-37.99-22.27-119.7
Upgrade
Short-Term Debt Repaid
-----12.88
Upgrade
Total Debt Repaid
-----12.88
Upgrade
Net Debt Issued (Repaid)
-----12.88
Upgrade
Issuance of Common Stock
743.75164.3842.3167.5137.28
Upgrade
Other Financing Activities
-0.24-0.39-0.34-0.410
Upgrade
Financing Cash Flow
743.5116441.95167.1134.39
Upgrade
Foreign Exchange Rate Adjustments
0.02-0.060.12-0.18-0.03
Upgrade
Net Cash Flow
363.3181.51-63.3195.54-27.16
Upgrade
Free Cash Flow
-82.18-70.06-67.44-49.38-42.17
Upgrade
Free Cash Flow Margin
-----4216.70%
Upgrade
Free Cash Flow Per Share
-0.88-0.88-0.95-1.37-1.86
Upgrade
Cash Income Tax Paid
0.220.060.0300.24
Upgrade
Levered Free Cash Flow
-55.48-43.26-36.12-27.38-10.9
Upgrade
Unlevered Free Cash Flow
-55.48-43.26-36.12-27.38-10.9
Upgrade
Change in Working Capital
-0.324.381.48-1.04-1.43
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.